Nico Myriad Spectra
Payments companies reported to CMS as associated with Nico Myriad Spectra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nico Myriad Spectra, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nico Myriad Spectra
These are the largest totals companies reported as associated with Nico Myriad Spectra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Constantinos Hadjipanayis | Pittsburgh, PA | Neurological Surgery | $450.00 |
| Jan Bian | Oklahoma City, OK | Otolaryngology | $171.99 |
| Colin Fuller | Oklahoma City, OK | Pediatric Otolaryngology | $171.99 |
| Tanner Mitton | Oklahoma City, OK | Otolaryngology | $171.99 |
| Wesley Greene | Oklahoma City, OK | Otolaryngology | $171.99 |
| Matthew Krutz | Oklahoma City, OK | Otolaryngology | $171.99 |
| Samuel Erickson | Oklahoma City, OK | Otolaryngology | $171.99 |
| Theodore Klug | Oklahoma City, OK | Otolaryngology | $171.99 |
| Vikram Ramjee | Oklahoma City, OK | Otolaryngology | $171.99 |
| Sean Abbott | Oklahoma City, OK | Otolaryngology | $171.99 |
Prescribed Nico Myriad Spectra?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.